Search…

Novonordisk's oral weight loss pill NVO.US has been approved by the FDA, entering a new round of the "battle of weight loss pills" with Eli Lilly.

23/12/2025

Zhtng Cijng APP noticed that, before the market opened on Tuesday, the stock price of Novo Nordisk (NVO.US) rose by 7.5%, after the Food and Drug Administration (FDA) in the United States approved its weight loss pill. This has given the company a competitive advantage in the rapidly evolving obesity treatment market.

Latest

2 m ago

After the release of the US GDP data, the US dollar index rose slightly, falling by 0.2% to 98.0 on the day.

2 m ago

Xinghua New Materials: To acquire 70% equity of Dongwang Technology for 140 million yuan, entering the fields of artificial intelligence and computing power.

2 m ago

After the GDP data in the United States came in stronger than expected, the euro gave back its gains against the dollar, with the latest increase of 0.2%, trading at $1.1782.

3 m ago

Guangzhou Futures Exchange: Starting from the settlement date of December 25, 2025, the daily price limit for platinum and palladium futures contracts will be adjusted to 10%, and the trading margin standard will be adjusted to 12%. In case of any inconsistency between the above-mentioned daily price limit and trading margin standard and the current ones, the greater limit and higher standard will be implemented.

3 m ago

After the release of the US Gross Domestic Product data, the US dollar narrowed its decline against the Japanese yen, with the latest exchange rate at 1 US dollar to 156.19 Japanese yen, a decrease of 0.5%.

See all latest